Faina Vikhanskaya

1.6k total citations
29 papers, 1.3k citations indexed

About

Faina Vikhanskaya is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Faina Vikhanskaya has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Molecular Biology and 13 papers in Biotechnology. Recurrent topics in Faina Vikhanskaya's work include Cancer-related Molecular Pathways (22 papers), Cancer Research and Treatments (12 papers) and RNA modifications and cancer (6 papers). Faina Vikhanskaya is often cited by papers focused on Cancer-related Molecular Pathways (22 papers), Cancer Research and Treatments (12 papers) and RNA modifications and cancer (6 papers). Faina Vikhanskaya collaborates with scholars based in Italy, Singapore and United Kingdom. Faina Vikhanskaya's co-authors include Massimo Broggini, Maurizio D’Incalci, Kanaga Sabapathy, Patrizia Russo, Mirko Marabese, Silvio Parodi, Marco Mazzoletti, Giovanna Damia, Eugenio Erba and Laura Carrassa and has published in prestigious journals such as Nucleic Acids Research, Nature Cell Biology and Oncogene.

In The Last Decade

Faina Vikhanskaya

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faina Vikhanskaya Italy 21 956 772 269 191 126 29 1.3k
Swati Palit Deb United States 19 966 1.0× 1000 1.3× 313 1.2× 250 1.3× 110 0.9× 39 1.5k
J Milner United Kingdom 17 1.1k 1.2× 901 1.2× 204 0.8× 298 1.6× 109 0.9× 23 1.6k
Yunping Lin Canada 10 1.6k 1.7× 1.1k 1.4× 411 1.5× 170 0.9× 159 1.3× 11 2.0k
Xiao Qi Wang Hong Kong 22 1.1k 1.1× 629 0.8× 394 1.5× 125 0.7× 115 0.9× 33 1.5k
Christian Wagener Germany 12 1.3k 1.4× 728 0.9× 222 0.8× 60 0.3× 167 1.3× 14 1.7k
Hilla Solomon Israel 20 1.1k 1.2× 883 1.1× 551 2.0× 149 0.8× 108 0.9× 29 1.8k
Shalom Madar Israel 22 1.0k 1.1× 736 1.0× 583 2.2× 86 0.5× 112 0.9× 27 1.6k
Gennaro Colella Italy 16 800 0.8× 439 0.6× 154 0.6× 51 0.3× 70 0.6× 29 1.1k
Maria Lokshin United States 9 1.2k 1.2× 862 1.1× 525 2.0× 254 1.3× 81 0.6× 9 1.5k
Sandra Muñoz-Galván Spain 18 661 0.7× 387 0.5× 215 0.8× 53 0.3× 132 1.0× 40 1.0k

Countries citing papers authored by Faina Vikhanskaya

Since Specialization
Citations

This map shows the geographic impact of Faina Vikhanskaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faina Vikhanskaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faina Vikhanskaya more than expected).

Fields of papers citing papers by Faina Vikhanskaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faina Vikhanskaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faina Vikhanskaya. The network helps show where Faina Vikhanskaya may publish in the future.

Co-authorship network of co-authors of Faina Vikhanskaya

This figure shows the co-authorship network connecting the top 25 collaborators of Faina Vikhanskaya. A scholar is included among the top collaborators of Faina Vikhanskaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faina Vikhanskaya. Faina Vikhanskaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marabese, Mirko, Marco Mazzoletti, Faina Vikhanskaya, & Massimo Broggini. (2008). HtrA2 enhances the apoptotic functions of p73 on bax. Cell Death and Differentiation. 15(5). 849–858. 22 indexed citations
2.
Vikhanskaya, Faina, et al.. (2007). Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53. Nucleic Acids Research. 35(6). 2093–2104. 118 indexed citations
3.
Marabese, Mirko, Sergio Marchini, Maria Antonietta Sabatino, et al.. (2005). Effects of inducible overexpression of DNp73α on cancer cell growth and response to treatment in vitro and in vivo. Cell Death and Differentiation. 12(7). 805–814. 17 indexed citations
4.
Vikhanskaya, Faina, et al.. (2005). Evaluation of the Combined Effect of p53 Codon 72 Polymorphism and Hotspot Mutations in Response to Anticancer Drugs. Clinical Cancer Research. 11(12). 4348–4356. 53 indexed citations
5.
Simone, Matteo, Eugenio Erba, Giovanna Damia, et al.. (2005). Variolin B and its derivate deoxy-variolin B: New marine natural compounds with cyclin-dependent kinase inhibitor activity. European Journal of Cancer. 41(15). 2366–2377. 54 indexed citations
6.
Carrassa, Laura, Massimo Broggini, Faina Vikhanskaya, & Giovanna Damia. (2003). Characterization of the 5’flanking Region of the Human chk1 Gene: Identification of E2F1 Functional Sites. Cell Cycle. 2(6). 603–608. 36 indexed citations
7.
Vikhanskaya, Faina & Massimo Broggini. (2002). Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients. International review of cytology. 219. 157–198. 8 indexed citations
8.
Damia, Giovanna, Faina Vikhanskaya, Laura Carrassa, et al.. (2001). Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation. Neoplasia. 3(1). 10–16. 68 indexed citations
9.
Vikhanskaya, Faina, Carla Falugi, Piera Valente, & Patrizia Russo. (2001). Human papillomavirus type 16 E6‐enhanced susceptibility to apoptosis induced by TNF in A2780 human ovarian cancer cell line. International Journal of Cancer. 97(6). 732–739. 24 indexed citations
10.
Vikhanskaya, Faina. (2000). p73 competes with p53 and attenuates its response in a human ovarian cancer cell line. Nucleic Acids Research. 28(2). 513–519. 47 indexed citations
11.
Vikhanskaya, Faina, Sara Vignati, Patrizia Beccaglia, et al.. (1998). Inactivation of p53 in a Human Ovarian Cancer Cell Line Increases the Sensitivity to Paclitaxel by Inducing G2/M Arrest and Apoptosis. Experimental Cell Research. 241(1). 96–101. 76 indexed citations
12.
Vikhanskaya, Faina, Mario Salmona, Gennaro Colella, et al.. (1998). Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.. PubMed. 58(16). 3654–9. 71 indexed citations
13.
Vikhanskaya, Faina, Monica Valenti, Maria Stanzione, et al.. (1997). Mechanism of resistance to cisplatin in a human ovarian‐carcinoma cell line selected for resistance to doxorubicin: Possible role of p53. International Journal of Cancer. 72(1). 155–159. 2 indexed citations
14.
Debernardis, Domizia, P. De Feudis, Faina Vikhanskaya, et al.. (1997). p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.. PubMed. 57(5). 870–4. 125 indexed citations
15.
Vikhanskaya, Faina, Monica Valenti, Maria Stanzione, et al.. (1997). Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53. International Journal of Cancer. 72(1). 155–159. 20 indexed citations
16.
Vikhanskaya, Faina, Eugenio Erba, Maurizio D’Incalci, & Massimo Broggini. (1996). Changes in Cyclins and Cyclin-Dependent Kinases Induced by DNA Damaging Agents in a Human Ovarian Cancer Cell Line Expressing Mutated or Wild-Type P53. Experimental Cell Research. 227(2). 380–385. 13 indexed citations
17.
Isaacs, R., Weg M. Ongkeko, Adrian L. Harris, et al.. (1996). p53 Regulates the Minimal Promoter of the Human Topoisomerase II  Gene. Nucleic Acids Research. 24(22). 4464–4470. 78 indexed citations
18.
Vikhanskaya, Faina & Maurizio D’Incalci. (1995). Decreased cytotoxic effects of doxorubicin in a human ovarian cancer‐cell line expressing wild‐type p53 and WAF1/CIP1 genes. International Journal of Cancer. 61(3). 397–401. 31 indexed citations
19.
Vikhanskaya, Faina, et al.. (1995). Sensitivity and cellular response to different anticancer agents of a human ovarian cancer cell line expressing wild-type, mutated or no p53. Annals of Oncology. 6(6). 589–593. 24 indexed citations
20.
Vikhanskaya, Faina, Eugenio Erba, M. D’lncalci, & Massimo Broggini. (1994). Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53. Nucleic Acids Research. 22(6). 1012–1017. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Swati Palit Deb Breakdown of academic impact, for papers by J Milner Breakdown of academic impact, for papers by Yunping Lin Breakdown of academic impact, for papers by Xiao Qi Wang Breakdown of academic impact, for papers by Christian Wagener Breakdown of academic impact, for papers by Hilla Solomon Breakdown of academic impact, for papers by Shalom Madar Breakdown of academic impact, for papers by Gennaro Colella Breakdown of academic impact, for papers by Maria Lokshin Breakdown of academic impact, for papers by Sandra Muñoz-Galván
Rankless by CCL
2026